Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Awakn Life Sciences N.AWKN

Alternate Symbol(s):  AWKNF

Awakn Life Sciences Corp is a Canadian biotechnology company with clinical operations researching, developing, and delivering psychedelic medicine to treat addiction.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

AWKN Featured News 6/15/22: Pioneering Psychedelic Therapies

Awakn Life Sciences Corp (OTCQB:AWKNF/ NEO:AWKN) Pioneering Psychedelic Therapies to treat AUD https://stockifymedia.com/awakn-life-sciences-corp-otcqbawknf-neoawkn-pioneering-psychedelic-therapies...read more

New CEO discussion from AWKN

https://youtu.be/lUQiFawTyNg  rate and reply

Excellent YT analysis on AWKN

https://youtu.be/123f1mNpt-Q  rate and reply

Awakn Life Sciences Receives $8.00 Price Target!

Prominent Investment banking firm Stifel GMP has recently published an analyst report issuing a BUY for Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF) with a price target of $8.00. To Read...read more

Successfully Complete Phase One of Its Drug Discovery Prog.

Two Chemical Series Identified to Facilitate Lead Optimisation Activities Toronto, Ontario--(Newsfile Corp. - April 6, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('...read more

Responds to OTC Markets Request

Toronto, Ontario--(Newsfile Corp. - January 14, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing and delivering...read more

New video covering AWKN trial results/news!

https://youtu.be/gF6BSOZAH0M  rate and reply

Excellent YT analysis on AWKN

https://youtu.be/RI20piHkvEc  rate and reply

new video interview

  rate and reply

Acquires Exclusive Rights to MDMA Research

This Was the World's First Published Study Assessing MDMA-Assisted Psychotherapy as a Treatment for Addiction Toronto, Ontario--(Newsfile Corp. - September 23, 2021) - Awakn Life Sciences Corp.,...read more

welcome to the Awaken Bullboard

Post and be merry.  rate and reply